Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer

Background: Within the claudin (CLDN) family, CLDN12 mRNA expression is altered in various types of cancer, but its clinicopathological relevance has yet to be established due to the absence of specific antibodies (Abs) with broad applications. Methods: We generated a monoclonal Ab (mAb) against human/mouse CLDN12 and verified its specificity. By performing immunohistochemical staining and semiquantification, we evaluated the relationship between CLDN12 expression and clinicopathological parameters in tissues from 138 cases of cervical cancer. Results: Western blot and immunohistochemical analyses revealed that the established mAb selectively recognized the CLDN12 protein. Twenty six of the 138 cases (18.8%) showed low CLDN12 expression, and the disease-specific survival (DSS) and recurrence-free survival rates were significantly decreased compared with those in the high CLDN12 expression group. We also demonstrated, via univariable and multivariable analyses, that the low CLDN12 expression represents a significant prognostic factor for the DSS of cervical cancer patients (HR 3.412, p = 0.002 and HR 2.615, p = 0.029, respectively). Conclusions: It can be concluded that a reduced CLDN12 expression predicts a poor outcome for cervical cancer. The novel anti-CLDN12 mAb could be a valuable tool to evaluate the biological relevance of the CLDN12 expression in diverse cancer types and other diseases.     

A CMOS multichannel 10-Gb/s transceiver

We describe a CMOS multichannel transceiver that transmits and receives 10 Gb/s per channel over balanced copper media. The transceiver consists of two identical 10-Gb/s modules. Each module operates off a single 1.2-V supply and has a single 5-GHz phase-locked loop to supply a reference clock to two transmitter (Tx) channels and two receiver (Rx) channels. To track the input-signal phase, the Rx channel has a clock recovery unit (CRU), which uses a phase-interpolator-based timing generator and digital loop filter. The CRU can adjust the recovered clock phase with a resolution of 1.56 ps. Two sets of two-channel transceiver units were fabricated in 0.11-/spl mu/m CMOS on a single test chip. The transceiver unit size was 1.6 mm /spl times/ 2.6 mm. The Rx sensitivity was 120-mVp-p differential with a 70-ps phase margin for a common-mode voltage ranging from 0.6 to 1.0 V. The evaluated jitter tolerance curve met the OC-192 specification.     

影响掺矿渣的钢纤维砼强度的主要因素

研究结果表明 :水胶比、胶凝材料用量、钢纤维掺量、矿渣代水泥量对钢纤维砼强度影响显著。当矿渣取代水泥 10 %时 ,钢纤维砼强度最高。经试验选择出一个具有良好和易性和较高强度 (118MPa)的钢纤维砼配合比 ,为掺磨细矿渣的中含量超短异形钢纤维砼的设计和施工提供了试验依据     

Effect of temperature on the strength and conductivity of a deformation processed Cu-20%Fe composite

The high temperature (22–600 °C) properties were evaluated for a Cu-20%Fe composite deformation processed from a powder metallurgy compact. The ultimate tensile strengths decreased with increasing temperature but were appreciably better than those of similarly processed Cu at temperatures up to 450 °C. At 600 °C, the strength of Cu-20%Fe was only slightly better than that of Cu as a result of the pronounced coarsening of the Fe filaments. However, at temperatures of 300 and 450 °C, the strength of Cu-20%Fe is about seven and six times greater, respectively, than that of Cu, as compared to about a two fold advantage at room temperature. Therefore, Cu-20%Fe composites made by deformation processing of powder metallurgy compacts have mechanical properties much superior to those of similarly processed Cu at room temperature and at temperatures up to 450 °C. The pronounced decrease in electrical conductivity of deformation processed Cu-20%Fe as compared to Cu is attributed to the appreciable dissolution of Fe into the Cu matrix which occurred during the fabrication of the starting compacts where temperatures up to 675 °C were used. While the powder metallurgy compacts used for the starting material for deformation processing in this study did not lead to a high conductivity composite, the powder metallurgy approach should still be a viable one if processing temperatures can be reduced further to prevent the dissolution of Fe into the Cu matrix.     

0.5-μm 3.3-V BiCMOS standard cells with 32-kilobyte cache andten-port register file

BiCMOS standard cell macros, including a 0.5-W 3-ns register file, a 0.6-W 5-ns 32-kbyte cache, a 0.2-W 3-ns table look-aside buffer (TLB), and a 0.1-W 3-ns adder, are designed with a 0.5-μm BiCMOS technology. A supply voltage of 3.3 V is used to achieve low power consumption. Several BiCMOS/CMOS circuits, such as a self-aligned threshold inverter (SATI) sense amplifier and an ECL HIT logic are used to realize high-speed operation at the low supply voltage. The performance of the BiCMOS macros is verified using a fabricated test chip     

The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts

Gastroesophageal reflux disease (GERD) is a disease with serious consequences that may result in significant impairment in quality of life and disease morbidity. Across all grades of severity of symptoms and severity of underlying esophageal disease, proton pump inhibitors (PPIs) provide therapeutic gains over prokinetics (PKs) or H2 receptor antagonists (H2RAs). The potential cost effectiveness of using medications with higher acquisition costs that may lower health care costs overall is often disregarded when conducting cost comparisons with medications having lower 'up-front' costs. Limiting therapy to less effective agents condemns many patients to protracted suffering, repeated physician visits and needless reinvestigation of symptoms that could have been resolved by appropriate initial therapy. Based on current data, use of any classification of symptom severity as a basis for selecting one class of therapeutic agents over another for first line therapy (i.e. PKs, H2RAs for 'mild' GERD, versus a PPI for 'severe' disease) is unwarranted.